NORCCAP (Norwegian colorectal cancer prevention): a randomised trial to assess the safety and efficacy of carbon dioxide versus air insufflation in colonoscopy

Por Bretthauer, M, Thiis-Evensen, E, Huppertz-Hauss, G, Gisselsson, L, Grotmol, T, Skovlund, E, Hoff, G
Publicado em 2002

Survival of patients with advanced urothelial cancer treated with cisplatin-based chemotherapy.

Por Fosså, S. D., Sternberg, C., Scher, H. I., Theodore, C. H., Mead, B., Dearnaley, D., Roberts, J. T., Skovlund, E.
Publicado em 1996

HER-2 activation and TP53 inactivation as predictors of survival in breast cancer

Por Andersen, TI, Skovlund, E, Bukholm, IK, Jacobsen, U, Kåresen, R, Erikstein, B, Nesland, J, Børresen-Dale, A-L
Publicado em 2000

Screening breast cancer patients for Norwegian ATM mutations

Por Laake, K, Vu, P, Andersen, TI, Erikstein, B, Kåresen, R, Lønning, PE, Skovlund, E, Børresen-Dale, A-L
Publicado em 2000

Screening breast cancer patients for Norwegian ATM mutations

Por Laake, K, Vu, P, Andersen, T I, Erikstein, B, Kåresen, R, Lønning, P E, Skovlund, E, Børresen-Dale, A L
Publicado em 2000

Monitoring of minimal residual cancer in bone marrow in high-risk breast cancer patients treated with high-dose chemotherapy

Por Drageset, V, Nesland, JM, Erikstein, B, Skovlund, E, Sommer, H, Anker, G, Wist, E, Lundgren, S, Bergh, J, Kvalheim, G
Publicado no Breast Cancer Res (2005)